Hansa Biopharma AB (HNSA.ST) Q4 2024 Earnings

17OctConfirmed
Q4 2023
Q1 2024
Q3 2024
Q4 2024
-3.6
-2.93
-2.25
-1.58

Details

Expected EPS
-2.497052594421
Actual EPS
-1.5808923899999998
Surprise EPS
0.92
Surprise Percent
+36.69%

Description

Hansa Biopharma AB (HNSA.ST) has reported earnings of -1.5808923899999998 per share for Q4 2024.

0 Comments

Share your thoughts